Cognex Corp (CGNX)

Industry Scientific & Technical Instruments


This stock can be held in an Investment ISA and an Investment Account
Sell

$65.26

Buy

$65.33

arrow-down$-0.73 (-1.11%)

Prices updated at 04 Jun 2026, 18:41 EDT
| Prices minimum 15 mins delay
|
Prices in USD

Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and ...

Income statement

20242025
915m994m
626m665m
115m163m
12.5816.35
106m114m
148m193m
Sales, General and administrative371m364m
Interest expenses--
Provision for income taxes25m68m
Operating expenses511m503m
Income before taxes131m183m
Net income available to common shareholders106m114m
0.620.68
Net interest income--
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)0.620.68
Free cash flow per share0.53381.2562
Book value/share9.19438.9201
Debt equity ratio0.0404370.043481

Balance sheet

20242025
Current assets613m697m
Current liabilities169m184m
Total capital1,518m1,492m
Total debt70m77m
Total equity1,518m1,492m
Total non current liabilities--
Loans--
Total assets1,993m2,017m
Total liabilities--
Cash and cash equivalents186m263m
Common stock170m167m

Cash flow

20242025
Cash at beginning of period203m186m
Cash dividends paid-52m-55m
134m237m
Investments (gains) losses-39m28m
186m263m
Net income--
149m246m
-15m-9m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.